{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:24:55Z","timestamp":1761989095257,"version":"3.41.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T00:00:00Z","timestamp":1498608000000},"content-version":"vor","delay-in-days":178,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Brasileira de Reumatologia (English Edition)"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1016\/j.rbre.2017.06.003","type":"journal-article","created":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T00:00:54Z","timestamp":1501027254000},"page":"484-496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"S2","title":["Recommendations of the Brazilian Society of Rheumatology for the induction therapy of ANCA-associated vasculitis"],"prefix":"10.1016","volume":"57","author":[{"given":"Alexandre Wagner Silva de","family":"Souza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Luisa","family":"Calich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrique de Ata\u00edde","family":"Mariz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuella Lima Gomes","family":"Ochtrop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Beatriz Santos","family":"Bacchiega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilda Aparecida","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jozelia","family":"R\u00eago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana Ortega","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa Maria Rodrigues","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanderley Marques","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger Abramino","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbre.2017.06.003_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rbre.2017.06.003_bib0010","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3389\/fimmu.2015.00184","article-title":"Autoantibodies in systemic vasculitis","volume":"6","author":"Silva de Souza","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.rbre.2017.06.003_bib0015","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/ard.2008.088096","article-title":"EULAR recommendations for the management of primary small and medium vessel vasculitis","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rbre.2017.06.003_bib0020","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","article-title":"EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis","volume":"75","author":"Yates","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rbre.2017.06.003_bib0025","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the Birmingham Vasculitis Activity Score (version 3)","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rbre.2017.06.003_bib0030","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/1529-0131(200104)44:4<912::AID-ANR148>3.0.CO;2-5","article-title":"International Network for the Study of the Systemic Vasculitides (INSSYS). A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score","volume":"44","author":"Stone","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rbre.2017.06.003_bib0035","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrrheum.2014.104","article-title":"Key advances in the clinical approach to ANCA-associated vasculitis","volume":"10","author":"Kallenberg","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.rbre.2017.06.003_bib0040","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"year":"2009","series-title":"Levels of Evidence (March 2009)","author":"Oxford Centre for Evidence-based Medicine","key":"10.1016\/j.rbre.2017.06.003_bib0045"},{"key":"10.1016\/j.rbre.2017.06.003_bib0050","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/bmj.39493.646875.AE","article-title":"Going from evidence to recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.rbre.2017.06.003_bib0055","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.rbre.2017.06.003_bib0060","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial","volume":"150","author":"de Groot","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rbre.2017.06.003_bib0065","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/art.21142","article-title":"Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"De Groot","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rbre.2017.06.003_bib0070","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","article-title":"Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis","volume":"18","author":"Jayne","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.rbre.2017.06.003_bib0075","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rbre.2017.06.003_bib0080","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rbre.2017.06.003_bib0085","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa041884","article-title":"Etanercept plus standard therapy for Wegener's granulomatosis","volume":"352","author":"Wegener's Granulomatosis Etanercept Trial (WGET) Research Group","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rbre.2017.06.003_bib0090","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/bmj.2.5091.265","article-title":"Giant-cell granuloma of the respiratory tract (Wegener's granulomatosis)","volume":"2","author":"Walton","year":"1958","journal-title":"Br Med J"},{"key":"10.1016\/j.rbre.2017.06.003_bib0095","doi-asserted-by":"crossref","first-page":"393","DOI":"10.7326\/0003-4819-67-2-393","article-title":"The use of alkylating agents in the treatment of Wegener's granulomatosis","volume":"67","author":"Hollander","year":"1967","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rbre.2017.06.003_bib0100","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/art.39104","article-title":"Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids","volume":"67","author":"Miloslavsky","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.rbre.2017.06.003_bib0105","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1056\/NEJMoa0802311","article-title":"Azathioprine or methotrexate maintenance for ANCA-associated vasculitis","volume":"359","author":"Pagnoux","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rbre.2017.06.003_bib0110","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1001\/jama.2010.1658","article-title":"Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial","volume":"304","author":"Hiemstra","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.rbre.2017.06.003_bib0115","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1404231","article-title":"Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis","volume":"371","author":"Guillevin","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rbre.2017.06.003_bib0120","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","article-title":"A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies","volume":"349","author":"Jayne","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rbre.2017.06.003_bib0125","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0002-9343(03)00077-9","article-title":"Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener's granulomatosis: extended follow-up and rate of relapse","volume":"114","author":"Langford","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.rbre.2017.06.003_bib0130","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/acr.20176","article-title":"Effects of duration of glucocorticoid therapy on relapse rate in antineutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis","volume":"62","author":"Walsh","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.rbre.2017.06.003_bib0135","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","article-title":"Wegener granulomatosis: an analysis of 158 patients","volume":"116","author":"Hoffman","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rbre.2017.06.003_bib0140","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.autrev.2012.08.007","article-title":"Treatment of ANCA-associated vasculitides (AAV)","volume":"12","author":"Holle","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.rbre.2017.06.003_bib0145","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/art.1780401213","article-title":"A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis","volume":"40","author":"Guillevin","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rbre.2017.06.003_bib0150","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/1529-0131(199810)41:10<1835::AID-ART16>3.0.CO;2-Q","article-title":"Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: a prospective, randomized study","volume":"41","author":"Haubitz","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rbre.2017.06.003_bib0155","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/qjmed\/90.6.401","article-title":"Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis","volume":"90","author":"Adu","year":"1997","journal-title":"QJM"},{"key":"10.1016\/j.rbre.2017.06.003_bib0160","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/annrheumdis-2011-200477","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up","volume":"71","author":"Harper","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rbre.2017.06.003_bib0165","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/art.1780351113","article-title":"The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate","volume":"35","author":"Hoffman","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rbre.2017.06.003_bib0170","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1002\/art.34547","article-title":"Brief Report: long-term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody-associated vasculitis","volume":"64","author":"Faurschou","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rbre.2017.06.003_bib0175","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1213277","article-title":"Efficacy of remission-induction regimens for ANCA-associated vasculitis","volume":"369","author":"Specks","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rbre.2017.06.003_bib0180","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1136\/annrheumdis-2014-206404","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial","volume":"74","author":"Jones","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rbre.2017.06.003_bib0185","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.lpm.2013.08.003","article-title":"Recommendations of the French Vasculitis Study Group (FVSG) for induction and maintenance treatments of adult, antineutrophil cytoplasm antibody-associated necrotizing vasculitides","volume":"42","author":"Charles","year":"2013","journal-title":"Presse Med"},{"key":"10.1016\/j.rbre.2017.06.003_bib0190","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/rheumatology\/ker150","article-title":"Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis","volume":"51","author":"Guerry","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rbre.2017.06.003_bib0195","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1093\/rheumatology\/ker106a","article-title":"BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis","volume":"50","author":"Bukhari","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rbre.2017.06.003_bib0200","first-page":"104","article-title":"I Consenso brasileiro sobre o uso de imunoglobulina humana em pacientes com imunodefici\u00eancias prim\u00e1rias","volume":"33","author":"Carvalho","year":"2010","journal-title":"Rev Bras Alerg Imunopatol"},{"key":"10.1016\/j.rbre.2017.06.003_bib0205","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/1471-2474-15-178","article-title":"The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease","volume":"15","author":"Marco","year":"2014","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.rbre.2017.06.003_bib0210","doi-asserted-by":"crossref","first-page":"e37626","DOI":"10.1371\/journal.pone.0037626","article-title":"Impact of rituximab on immunoglobulin concentrations and B cell numbers after cyclophosphamide treatment in patients with ANCA-associated vasculitides","volume":"7","author":"Venhoff","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.rbre.2017.06.003_bib0215","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0140-6736(76)93089-0","article-title":"Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome","volume":"1","author":"Lockwood","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.rbre.2017.06.003_bib0220","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/ki.1991.272","article-title":"Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies","volume":"40","author":"Pusey","year":"1991","journal-title":"Kidney Int"},{"key":"10.1016\/j.rbre.2017.06.003_bib0225","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/ndt\/gfq360","article-title":"Plasma exchange for induction and cyclosporine A for maintenance of remission in Wegener's granulomatosis \u2013 a clinical randomized controlled trial","volume":"26","author":"Szpirt","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.rbre.2017.06.003_bib0230","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/ki.2013.131","article-title":"Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear","volume":"84","author":"Walsh","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.rbre.2017.06.003_bib0235","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1745-6215-14-73","article-title":"Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial","volume":"14","author":"Walsh","year":"2013","journal-title":"Trials"},{"key":"10.1016\/j.rbre.2017.06.003_bib0240","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2249.1995.tb02268.x","article-title":"Treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis with high-dose intravenous immunoglobulin","volume":"101","author":"Richter","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.rbre.2017.06.003_bib0245","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.7883\/yoken.JJID.2004.S17","article-title":"Intravenous immunoglobulin (IVIg) therapy in MPO-ANCA related polyangiitis with rapidly progressive glomerulonephritis in Japan","volume":"57","author":"Muso","year":"2004","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.rbre.2017.06.003_bib0250","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/art.23147","article-title":"Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients","volume":"58","author":"Martinez","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rbre.2017.06.003_bib0255","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/qjmed\/93.7.433","article-title":"Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity","volume":"93","author":"Jayne","year":"2000","journal-title":"QJM"},{"key":"10.1016\/j.rbre.2017.06.003_bib0260","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/art.39472","article-title":"Intravenous immunoglobulin as an immunomodulating agent in antineutrophil cytoplasmic antibody-associated vasculitides: a French nationwide study of ninety-two patients","volume":"68","author":"Crickx","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.rbre.2017.06.003_bib0265","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/ndt\/gfm780","article-title":"Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement","volume":"23","author":"Hu","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.rbre.2017.06.003_bib0270","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000324364","article-title":"Effects of mycophenolate mofetil combined with corticosteroids for induction therapy of microscopic polyangiitis","volume":"33","author":"Han","year":"2011","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.rbre.2017.06.003_bib0275","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1002\/art.30394","article-title":"Solid malignancies among etanercept-treated patients with granulomatosis with polyangiitis (Wegener's): long-term followup of a multicenter longitudinal cohort","volume":"63","author":"Silva","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rbre.2017.06.003_bib0280","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1002\/art.1780391020","article-title":"Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis","volume":"39","author":"Langford","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"12 Pt 1","key":"10.1016\/j.rbre.2017.06.003_bib0285","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1288\/00005537-199212000-00005","article-title":"The management of subglottic stenosis in patients with Wegener's granulomatosis","volume":"102","author":"Lebovics","year":"1992","journal-title":"Laryngoscope"},{"key":"10.1016\/j.rbre.2017.06.003_bib0290","first-page":"1017","article-title":"Treatment of subglottic stenosis, due to Wegener's granulomatosis, with intralesional corticosteroids and dilation","volume":"30","author":"Hoffman","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rbre.2017.06.003_bib0295","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/thx.2007.078915","article-title":"Results of endoscopic surgery and intralesional steroid therapy for airway compromise due to tracheobronchial Wegener's granulomatosis","volume":"63","author":"Nouraei","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.rbre.2017.06.003_bib0300","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1002\/lary.21121","article-title":"Intralesional corticosteroid injection and dilatation provides effective management of subglottic stenosis in Wegener's granulomatosis","volume":"120","author":"Wolter","year":"2010","journal-title":"Laryngoscope"},{"key":"10.1016\/j.rbre.2017.06.003_bib0305","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00405-012-2240-z","article-title":"Treatment for adult idiopathic and Wegener-associated subglottic stenosis","volume":"270","author":"Gouveris","year":"2013","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.rbre.2017.06.003_bib0310","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1001\/jamaoto.2014.2430","article-title":"Long-term outcome of airway stenosis in granulomatosis with polyangiitis (Wegener granulomatosis): an observational study","volume":"140","author":"Martinez Del Pero","year":"2014","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.rbre.2017.06.003_bib0315","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/00005537-200308000-00008","article-title":"Subglottic stenosis associated with Wegener's granulomatosis","volume":"113","author":"Gluth","year":"2003","journal-title":"Laryngoscope"},{"issue":"Suppl 3","key":"10.1016\/j.rbre.2017.06.003_bib0320","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.3949\/ccjm.79.s3.04","article-title":"Upper airway manifestations of granulomatosis with polyangiitis","volume":"79","author":"Alam","year":"2012","journal-title":"Cleve Clin J Med"},{"issue":"4 Pt 2","key":"10.1016\/j.rbre.2017.06.003_bib0325","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.lpm.2013.01.024","article-title":"L24. Local treatments of subglottic and tracheal stenoses in granulomatosis with polyangiitis (Wegener's)","volume":"42","author":"Rasmussen","year":"2013","journal-title":"Presse Med"},{"key":"10.1016\/j.rbre.2017.06.003_bib0330","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1097\/00005537-200411000-00038","article-title":"Caution in using subglottic stents for Wegener's granulomatosis","volume":"114","author":"Mair","year":"2004","journal-title":"Laryngoscope"},{"key":"10.1016\/j.rbre.2017.06.003_bib0335","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/rheumatology\/40.5.492","article-title":"Analysis of factors predictive of survival based on 49 patients with systemic Wegener's granulomatosis and prospective follow-up","volume":"40","author":"Mahr","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rbre.2017.06.003_bib0340","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/art.20082","article-title":"Predicting mortality in systemic Wegener's granulomatosis: a survival analysis based on 93 patients","volume":"51","author":"Bligny","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rbre.2017.06.003_bib0345","first-page":"CD005590","article-title":"Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients","author":"Stern","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rbre.2017.06.003_bib0350","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3109\/s10165-011-0525-5","article-title":"Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV study","volume":"22","author":"Ozaki","year":"2012","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.rbre.2017.06.003_bib0355","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/eci.12410","article-title":"Frequency, risk factors and prophylaxis of infection in ANCA-associated vasculitis","volume":"45","author":"Kronbichler","year":"2015","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.rbre.2017.06.003_bib0360","unstructured":"Sociedade Brasileira de Reumatologia & Sociedade Brasileira de Imunologia. Reumatologia: Guia de Imuniza\u00e7\u00e3o SBIm\/SBR; Magic\/RM; 2014\/2015."},{"issue":"Suppl 5Pt 2","key":"10.1016\/j.rbre.2017.06.003_bib0365","first-page":"819","article-title":"Antibody response to inactivated subunit influenza vaccine in patients with Wegener's granulomatosis","volume":"58","author":"Zycinska","year":"2007","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.rbre.2017.06.003_bib0370","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/ndt\/gfm640","article-title":"Influenza vaccination does not result in an increase in relapses in patients with ANCA-associated vasculitis","volume":"23","author":"Stassen","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.rbre.2017.06.003_bib0375","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/ard.2008.092924","article-title":"Wegener's granulomatosis patients show an adequate antibody response to influenza vaccination","volume":"68","author":"Holvast","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rbre.2017.06.003_bib0380","article-title":"Failure of pneumococcal immunization during remission induction treatment of ANCA-associated vasculitis: the Pneumovas Pilot 1 study","author":"Groh","year":"2016","journal-title":"Joint Bone Spine"}],"container-title":["Revista Brasileira de Reumatologia (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2255502117300433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2255502117300433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T17:58:46Z","timestamp":1750787926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2255502117300433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":76,"alternative-id":["S2255502117300433"],"URL":"https:\/\/doi.org\/10.1016\/j.rbre.2017.06.003","relation":{},"ISSN":["2255-5021"],"issn-type":[{"type":"print","value":"2255-5021"}],"subject":[],"published":{"date-parts":[[2017]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommendations of the Brazilian Society of Rheumatology for the induction therapy of ANCA-associated vasculitis","name":"articletitle","label":"Article Title"},{"value":"Revista Brasileira de Reumatologia (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbre.2017.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rbr.2017.05.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}